Key Takeaways
Intercept, a new $500 million philanthropic fund, launched June 24 to make respiratory infections like the common cold and flu a thing of the past, according to MIT Technology Review.
Anchor funders include Stripe, Anthropic, the OpenAI Foundation, the Flu Lab, Bill Gates, and traders from Jane Street, with money aimed at broad-spectrum preventatives and air cleaning.
Respiratory viruses kill roughly 1 million people a year and cost an estimated $600 billion in lost productivity, the kind of public good that markets and donors have left underfunded.
A group of technology companies and billionaire donors is putting $500 million behind a single goal, ending respiratory infections. The fund, called Intercept, launched June 24 and is backed by Stripe, Anthropic, the OpenAI Foundation, the Flu Lab, Bill Gates, and several traders at Jane Street, according to MIT Technology Review and TIME.
Intercept is led by Nan Ransohoff, who previously ran Stripe's climate program. The case she laid out at launch is that respiratory viruses get treated as a minor nuisance when the numbers say otherwise. People spend roughly 5 percent of their lives sick from them, the viruses kill about 1 million people a year, cost an estimated $600 billion in annual productivity, and periodically threaten the world with pandemics.
The fund will use grants and investments to push two kinds of products. The first is broad-spectrum preventatives, a shot, nasal spray, or pill that could defend against rhinoviruses, influenza, coronaviruses, and other families at once. The second is air-cleaning technology, including advanced filtration and far-UVC light, a wavelength that can inactivate pathogens in the air and on surfaces in schools, offices, and other public spaces.
Intercept's organizers say broad-spectrum solutions have long been underfunded because they fit neither most philanthropic nor commercial funding. Its advisers include Peter Marks, a former top FDA vaccine official, and Moncef Slaoui, who led the US vaccine push Operation Warp Speed, per Intercept.
The framing from Stripe is worth sitting with. Important public goods can fail to exist simply because the commercial incentives are not there yet. It is the same gap visible in the Chan Zuckerberg Biohub's $500 million open biology dataset and in a year when US charitable giving hit a record $617 billion while the hardest problems stayed underfunded. Whether $500 million is enough to bend a problem this big is the open question. Worth watching.
People Also Ask
What is the Intercept Fund?
Intercept is a $500 million philanthropic initiative launched June 24, 2026, that aims to make respiratory infections like the common cold and flu a thing of the past by funding preventatives and air-cleaning technology.
Who is funding Intercept?
Anchor funders include Stripe, Anthropic, the OpenAI Foundation, the Flu Lab, Bill Gates, and several traders at Jane Street, according to MIT Technology Review.
What is far-UVC light and how does it fit in?
Far-UVC is a specific wavelength of ultraviolet light that can inactivate viruses in the air and on surfaces. Intercept plans to back it alongside air filtration to clean indoor air in public spaces.
Why have respiratory viruses been hard to solve?
Intercept's organizers say broad-spectrum solutions have been underfunded because they fit neither most philanthropic nor commercial funding, even though the viruses kill about 1 million people a year.
Sources: MIT Technology Review, TIME, Nan Ransohoff (X), interceptfund.com.